3 Reasons Why Enzyme Finance (MLN) Is Up 92% in a Week

·

The decentralized finance (DeFi) sector continues to demonstrate its resilience and innovation potential, even amid broader market volatility. One standout performer in recent weeks has been Enzyme Finance (MLN), a protocol redefining on-chain asset management by empowering users to create and scale investment vaults based on customized strategies.

After a quiet stretch in mid-2021, MLN surged 92% in just seven days—climbing from $65 on June 30 to an intraday high of $125 on July 5. This impressive rally was fueled by a combination of strategic developments that boosted visibility, usability, and trust in the platform.

Behind this momentum are three key catalysts: new exchange listings, a high-impact DeFi partnership, and a doubling of total value locked (TVL). Together, these factors have reinvigorated investor interest and positioned Enzyme Finance as one of the most talked-about protocols in the DeFi ecosystem.

👉 Discover how leading DeFi platforms are shaping the future of digital asset management.

Exchange Listings Spark Surge in Liquidity and Volume

One of the most immediate triggers for Enzyme’s price surge was its listing on major cryptocurrency exchanges—most notably Binance, the world’s largest crypto exchange by trading volume.

On July 5, Binance announced it would begin trading MLN against USDT, triggering a wave of buying pressure. The news alone sent MLN’s price up by 55% within hours, reaching a peak of $125. More significantly, the 24-hour trading volume exploded by over **2,000%**, jumping to $148 million—a clear sign of renewed market appetite.

This wasn’t an isolated listing. Around the same time, Gate.io also added MLN to its trading roster, further expanding global access. These listings followed Enzyme’s earlier debut on Coinbase, the top U.S.-based exchange, marking a strategic rollout across tier-one platforms.

Such listings do more than just increase token visibility—they enhance liquidity, reduce slippage, and attract institutional-grade traders who rely on reputable exchanges for compliance and security. For a niche protocol like Enzyme, being listed on Binance is akin to gaining mainstream validation in the crypto world.

Why Exchange Listings Matter in DeFi

While fundamental utility drives long-term value, exchange listings often serve as short-term accelerants. They open doors to millions of new users and provide exposure through exchange promotions, trading competitions, and built-in analytics tools.

For MLN, the timing couldn’t have been better. With DeFi regaining traction after a market lull, Binance’s endorsement acted as a powerful signal to retail and professional investors alike.

👉 See how top-tier exchange support can transform emerging blockchain projects.

Strategic Partnership with Yearn.finance Boosts Utility

Beyond market access, Enzyme Finance strengthened its core functionality through a pivotal collaboration with Yearn.finance, one of DeFi’s most respected yield optimization platforms.

On July 5, Enzyme announced that Yearn Vaults are now integrated into its ecosystem, allowing portfolio managers on the Enzyme app to incorporate Yearn’s automated yield farming strategies directly into their investment offerings.

This integration means asset managers can:

Yearn.finance has built a reputation for reliability and innovation across multiple blockchains, making it a trusted partner in the DeFi space. By integrating Yearn’s infrastructure, Enzyme enhances its appeal to sophisticated users seeking diversified, high-efficiency strategies.

Moreover, this move aligns with the broader trend toward interoperability in DeFi—where protocols no longer operate in silos but instead combine forces to deliver superior financial products.

The Power of Composable Finance

DeFi’s strength lies in its "money lego" philosophy—where independent protocols stack together like building blocks. Enzyme’s integration with Yearn exemplifies this concept perfectly.

It transforms Enzyme from a standalone vault builder into a comprehensive asset management hub, capable of pulling yield-generating components from across the DeFi landscape.

As more protocols adopt this modular approach, users benefit from greater flexibility, transparency, and control over their digital assets—all without relying on traditional financial intermediaries.

Total Value Locked Doubles Amid Growing Institutional Interest

Perhaps the most telling sign of Enzyme’s growing credibility is the dramatic rise in total value locked (TVL)—a key metric for measuring user trust and protocol adoption.

According to data from DeFi Pulse, Enzyme’s TVL more than doubled between June and July 2021, climbing from $40 million to over **$110 million**. This surge wasn’t driven by speculative inflows alone but by strategic capital deployment from institutional players.

A major contributor was Unslashed Finance, a decentralized insurance protocol that allocated 4,000 ETH into yield strategies hosted on Enzyme. The goal? To strengthen Unslashed’s capital base for future insurance payouts while earning passive returns.

“Another new ATH with 225% spike in Enzyme TVL yesterday as @UnslashedF deploys into yield strategies to buffer up their capital base for insurance.”

— Enzyme Finance (June 16, 2021)

This type of institutional-grade participation signals confidence in Enzyme’s smart contract security, governance model, and long-term viability. Unlike retail-driven pumps, capital from protocols like Unslashed tends to be longer-term and mission-aligned.

Additionally, higher TVL improves protocol sustainability by:

With more protocols viewing Enzyme as a secure layer for managing treasury assets or offering structured investment products, the flywheel of growth begins to spin faster.

FAQ: Common Questions About Enzyme Finance (MLN)

Q: What is Enzyme Finance used for?
A: Enzyme Finance enables users to create and manage on-chain investment vaults using customizable strategies. It's designed for both individual investors and institutions looking to automate asset management in DeFi.

Q: How does MLN token gain value?
A: The MLN token benefits from deflationary mechanics—management fees collected by vaults are used to buy back and burn MLN, reducing supply over time. Increased usage leads to more burns, potentially increasing scarcity and value.

Q: Is Enzyme Finance safe to use?
A: The protocol has undergone multiple third-party audits and runs on Ethereum with transparent smart contracts. However, as with all DeFi platforms, users should understand smart contract risks and do their own research.

Q: Can I earn yield with Enzyme?
A: Yes. Users can invest in existing vaults or create their own, leveraging integrations with top protocols like Yearn.finance to generate returns through lending, staking, and yield farming.

Q: How does Enzyme differ from other DeFi asset managers?
A: Enzyme stands out due to its modular architecture, cross-protocol integrations, and focus on permissionless innovation. Its compatibility with Yearn and support for complex investment logic make it highly flexible compared to simpler vault solutions.

Q: Where can I trade MLN?
A: MLN is available on major exchanges including Binance, Coinbase, and Gate.io, providing strong liquidity and global accessibility.


Enzyme Finance’s recent rally reflects more than just short-term speculation—it highlights a maturing protocol gaining real traction in the DeFi ecosystem. With enhanced exchange visibility, strategic partnerships, and rising institutional adoption, MLN is proving its relevance in a competitive landscape.

As decentralized asset management evolves, platforms like Enzyme are paving the way for a future where anyone can launch sophisticated financial products without gatekeepers or intermediaries.

Whether you're an investor tracking performance or a developer exploring composable finance tools, now is a compelling time to understand what makes Enzyme Finance tick.

👉 Explore next-generation DeFi opportunities with secure, scalable platforms.